XML 19 R7.htm IDEA: XBRL DOCUMENT v3.25.4
Consolidated Statements of Changes in Shareholders' Equity - USD ($)
$ in Thousands
Total
Cumulative effect adjustment upon adoption of ASC 326
Adjusted beginning balance
Preferred Stock
Preferred Stock
Adjusted beginning balance
Common Stock
Common Stock
Adjusted beginning balance
Retained Earnings
Retained Earnings
Cumulative effect adjustment upon adoption of ASC 326
Retained Earnings
Adjusted beginning balance
Accumulated Other Comprehensive Income (Loss)
Accumulated Other Comprehensive Income (Loss)
Adjusted beginning balance
Beginning balance, preferred stock (in shares) at Dec. 31, 2022       69,141                
Beginning balance, common stock (in shares) at Dec. 31, 2022           14,625,474            
Beginning balance at Dec. 31, 2022 $ 335,442 $ (1,886) $ 333,556 $ 69,141 $ 69,141 $ 149,631 $ 149,631 $ 127,181 $ (1,886) $ 125,295 $ (10,511) $ (10,511)
Comprehensive income                        
Net income 30,705             30,705        
Other comprehensive income, net of tax 1,587                   1,587  
Issuance of restricted stock (in shares)           3,300            
Forfeiture of restricted stock (in shares)           (500)            
Restricted stock surrendered due to employee tax liability (in shares)           (99)            
Restricted stock surrendered due to employee tax liability $ (2)         $ (2)            
Repurchase of common stock (in shares) (512,657)         (512,657)            
Repurchase of common stock $ (8,828)         $ (8,828)            
Stock repurchase excise tax (76)         (76)            
Share-based compensation expense 488         $ 488            
Stock options exercised (in shares)           144,922            
Stock options exercised 1,350         $ 1,350            
Cash dividends declared on common stock (9,908)             (9,908)        
Ending balance, preferred stock (in shares) at Dec. 31, 2023       69,141                
Ending balance, common stock (in shares) at Dec. 31, 2023           14,260,440            
Ending balance at Dec. 31, 2023 348,872     $ 69,141   $ 142,563   146,092     (8,924)  
Comprehensive income                        
Net income 25,810             25,810        
Other comprehensive income, net of tax (395)                   (395)  
Issuance of restricted stock (in shares)           101,500            
Forfeiture of restricted stock (in shares)           (420)            
Restricted stock surrendered due to employee tax liability (in shares)           (150)            
Restricted stock surrendered due to employee tax liability $ (3)         $ (3)            
Repurchase of common stock (in shares) (14,947)         (14,947)            
Repurchase of common stock $ (222)         $ (222)            
Share-based compensation expense 504         $ 504            
Stock options exercised (in shares)           34,228            
Stock options exercised 353         $ 353            
Preferred stock dividends (834)             (834)        
Cash dividends declared on common stock $ (10,271)             (10,271)        
Ending balance, preferred stock (in shares) at Dec. 31, 2024 69,141     69,141                
Ending balance, common stock (in shares) at Dec. 31, 2024 14,380,651         14,380,651            
Ending balance at Dec. 31, 2024 $ 363,814     $ 69,141   $ 143,195   160,797     (9,319)  
Comprehensive income                        
Net income 37,453             37,453        
Other comprehensive income, net of tax 4,463                   4,463  
Issuance of restricted stock (in shares)           6,200            
Forfeiture of restricted stock (in shares)           (1,500)            
Restricted stock surrendered due to employee tax liability (in shares)           (3,404)            
Restricted stock surrendered due to employee tax liability $ (81)         $ (81)            
Repurchase of common stock (in shares) (358,251)         (358,251)            
Repurchase of common stock $ (7,101)         $ (7,101)            
Stock repurchase excise tax (8)         (8)            
Share-based compensation expense $ 973         $ 973            
Stock options exercised (in shares) 206,732         206,732            
Stock options exercised $ 2,278         $ 2,278            
Preferred stock dividends (300)             (300)        
Cash dividends declared on common stock $ (11,465)             (11,465)        
Ending balance, preferred stock (in shares) at Dec. 31, 2025 69,141     69,141                
Ending balance, common stock (in shares) at Dec. 31, 2025 14,230,428         14,230,428            
Ending balance at Dec. 31, 2025 $ 390,026     $ 69,141   $ 139,256   $ 186,485     $ (4,856)